Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

Year in Review: Top Prevention Stories of 2025

News Daily News

Year in Review: Top Prevention Stories of 2025

Michael O'Riordan

December 24, 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

November 18, 2025

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

July 21, 2025

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

News Daily News

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

July 14, 2025

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

June 25, 2025

Amylin Analogue Boosts Weight Loss When Added to GLP-1

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

June 24, 2025

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

June 12, 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

Tirzepatide Tops Semaglutide for Weight Loss SURMOUNT-5

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

Medicaid Patients with Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

April 17, 2025

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

January 09, 2025

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

News Daily News

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

December 23, 2024

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

December 13, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

October 23, 2024

Liraglutide Helps Shed Weight in Young Children With Obesity

News Daily News

Liraglutide Helps Shed Weight in Young Children With Obesity

September 13, 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

July 22, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.